NewsDesk @bactiman63 Since large parts of Danish society were shut down on 12 March 2020 due to Covid-19, the incidence of influenza has been at a very low level until the beginning of 2022. Now the number...

NewsDesk  @infectiousdiseasenews The Swedish Public Health Agency, or Folkhälsomyndigheten says the flu epidemic is underway for the season and there is a risk that it will be intense. Since the beginning...

The Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) Health Advisory about increased influenza A(H3N2) activity that could mark the beginning of the 2021-2022 influenza...

Seqirus today announced that the U.S. Food and Drug Administration (FDA) has granted supplemental approval of a multi-dose vial (MDV) presentation of AUDENZ™ (Influenza A(H5N1) Monovalent Vaccine, Adjuvanted),...

NewsDesk @bactiman63 Clinical-stage vaccine company, FluGen today announced the publication of results from its Phase 2 human challenge study of Bris2007 M2SR, the Company’s investigational, supra-seasonal,...

Biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, Moderna, announced Wednesday  the first participants have been dosed in the Phase 1/2 study of mRNA-1010, the Company’s...

People who received a flu shot last flu season were significantly less likely to test positive for a COVID-19 infection when the pandemic hit, according to a new study. And those who did test positive...

An experimental single-dose, intranasal influenza vaccine was safe and produced a durable immune response when tested in a Phase 1 study published in the Journal of Clinical Investigation. The investigational...

By NewsDesk  @bactiman63 Public Health England reported this week three-quarters (75%) of those aged 65 and over in England received the free vaccine so far this year – up from 72.4% at the end of...

Osivax announced today that it has received over EUR 30M in public funding from different sources to support the development of universal vaccines against coronavirus and influenza. The Company’s proprietary oligoDOM®...